As interest in psychedelic therapy grows, more Americans are traveling abroad for treatments that remain restricted in the United States. Reports of inadequate medical screening, serious complications, and sexual abuse have raised concerns about patient safety. The cases raise urgent bioethics questions about informed consent, patient autonomy, and accountability in a fast growing but largely unregulated field of medicine. Read more here.